Copyright Reports & Markets. All rights reserved.

Global Anesthesia Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Anesthesia Drugs
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Anesthesia Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Propofol
    • 1.3.3 Etomidate
    • 1.3.4 Midazolam
    • 1.3.5 Sevoflurane
    • 1.3.6 Isoflurane
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Anesthesia Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Intravenous Anesthetics
    • 1.4.3 Inhalational Anesthetics
  • 1.5 Global Anesthesia Drugs Market Size & Forecast
    • 1.5.1 Global Anesthesia Drugs Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Anesthesia Drugs Sales Quantity (2019-2030)
    • 1.5.3 Global Anesthesia Drugs Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Astrazeneca
    • 2.1.1 Astrazeneca Details
    • 2.1.2 Astrazeneca Major Business
    • 2.1.3 Astrazeneca Anesthesia Drugs Product and Services
    • 2.1.4 Astrazeneca Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Astrazeneca Recent Developments/Updates
  • 2.2 Fresenius-Kabi
    • 2.2.1 Fresenius-Kabi Details
    • 2.2.2 Fresenius-Kabi Major Business
    • 2.2.3 Fresenius-Kabi Anesthesia Drugs Product and Services
    • 2.2.4 Fresenius-Kabi Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Fresenius-Kabi Recent Developments/Updates
  • 2.3 AbbVie
    • 2.3.1 AbbVie Details
    • 2.3.2 AbbVie Major Business
    • 2.3.3 AbbVie Anesthesia Drugs Product and Services
    • 2.3.4 AbbVie Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 AbbVie Recent Developments/Updates
  • 2.4 Baxter Healthcare
    • 2.4.1 Baxter Healthcare Details
    • 2.4.2 Baxter Healthcare Major Business
    • 2.4.3 Baxter Healthcare Anesthesia Drugs Product and Services
    • 2.4.4 Baxter Healthcare Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Baxter Healthcare Recent Developments/Updates
  • 2.5 B.Braun
    • 2.5.1 B.Braun Details
    • 2.5.2 B.Braun Major Business
    • 2.5.3 B.Braun Anesthesia Drugs Product and Services
    • 2.5.4 B.Braun Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 B.Braun Recent Developments/Updates
  • 2.6 Maruishi
    • 2.6.1 Maruishi Details
    • 2.6.2 Maruishi Major Business
    • 2.6.3 Maruishi Anesthesia Drugs Product and Services
    • 2.6.4 Maruishi Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Maruishi Recent Developments/Updates
  • 2.7 Piramal
    • 2.7.1 Piramal Details
    • 2.7.2 Piramal Major Business
    • 2.7.3 Piramal Anesthesia Drugs Product and Services
    • 2.7.4 Piramal Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Piramal Recent Developments/Updates
  • 2.8 Hikma Pharmaceuticals
    • 2.8.1 Hikma Pharmaceuticals Details
    • 2.8.2 Hikma Pharmaceuticals Major Business
    • 2.8.3 Hikma Pharmaceuticals Anesthesia Drugs Product and Services
    • 2.8.4 Hikma Pharmaceuticals Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Hikma Pharmaceuticals Recent Developments/Updates
  • 2.9 Mylan
    • 2.9.1 Mylan Details
    • 2.9.2 Mylan Major Business
    • 2.9.3 Mylan Anesthesia Drugs Product and Services
    • 2.9.4 Mylan Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Mylan Recent Developments/Updates
  • 2.10 Nhwa
    • 2.10.1 Nhwa Details
    • 2.10.2 Nhwa Major Business
    • 2.10.3 Nhwa Anesthesia Drugs Product and Services
    • 2.10.4 Nhwa Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Nhwa Recent Developments/Updates
  • 2.11 Hengrui
    • 2.11.1 Hengrui Details
    • 2.11.2 Hengrui Major Business
    • 2.11.3 Hengrui Anesthesia Drugs Product and Services
    • 2.11.4 Hengrui Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Hengrui Recent Developments/Updates
  • 2.12 Lunan
    • 2.12.1 Lunan Details
    • 2.12.2 Lunan Major Business
    • 2.12.3 Lunan Anesthesia Drugs Product and Services
    • 2.12.4 Lunan Anesthesia Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Lunan Recent Developments/Updates

3 Competitive Environment: Anesthesia Drugs by Manufacturer

  • 3.1 Global Anesthesia Drugs Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Anesthesia Drugs Revenue by Manufacturer (2019-2024)
  • 3.3 Global Anesthesia Drugs Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Anesthesia Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Anesthesia Drugs Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Anesthesia Drugs Manufacturer Market Share in 2023
  • 3.5 Anesthesia Drugs Market: Overall Company Footprint Analysis
    • 3.5.1 Anesthesia Drugs Market: Region Footprint
    • 3.5.2 Anesthesia Drugs Market: Company Product Type Footprint
    • 3.5.3 Anesthesia Drugs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Anesthesia Drugs Market Size by Region
    • 4.1.1 Global Anesthesia Drugs Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Anesthesia Drugs Consumption Value by Region (2019-2030)
    • 4.1.3 Global Anesthesia Drugs Average Price by Region (2019-2030)
  • 4.2 North America Anesthesia Drugs Consumption Value (2019-2030)
  • 4.3 Europe Anesthesia Drugs Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Anesthesia Drugs Consumption Value (2019-2030)
  • 4.5 South America Anesthesia Drugs Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Anesthesia Drugs Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Anesthesia Drugs Sales Quantity by Type (2019-2030)
  • 5.2 Global Anesthesia Drugs Consumption Value by Type (2019-2030)
  • 5.3 Global Anesthesia Drugs Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Anesthesia Drugs Sales Quantity by Application (2019-2030)
  • 6.2 Global Anesthesia Drugs Consumption Value by Application (2019-2030)
  • 6.3 Global Anesthesia Drugs Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Anesthesia Drugs Sales Quantity by Type (2019-2030)
  • 7.2 North America Anesthesia Drugs Sales Quantity by Application (2019-2030)
  • 7.3 North America Anesthesia Drugs Market Size by Country
    • 7.3.1 North America Anesthesia Drugs Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Anesthesia Drugs Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Anesthesia Drugs Sales Quantity by Type (2019-2030)
  • 8.2 Europe Anesthesia Drugs Sales Quantity by Application (2019-2030)
  • 8.3 Europe Anesthesia Drugs Market Size by Country
    • 8.3.1 Europe Anesthesia Drugs Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Anesthesia Drugs Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Anesthesia Drugs Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Anesthesia Drugs Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Anesthesia Drugs Market Size by Region
    • 9.3.1 Asia-Pacific Anesthesia Drugs Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Anesthesia Drugs Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Anesthesia Drugs Sales Quantity by Type (2019-2030)
  • 10.2 South America Anesthesia Drugs Sales Quantity by Application (2019-2030)
  • 10.3 South America Anesthesia Drugs Market Size by Country
    • 10.3.1 South America Anesthesia Drugs Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Anesthesia Drugs Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Anesthesia Drugs Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Anesthesia Drugs Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Anesthesia Drugs Market Size by Country
    • 11.3.1 Middle East & Africa Anesthesia Drugs Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Anesthesia Drugs Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Anesthesia Drugs Market Drivers
  • 12.2 Anesthesia Drugs Market Restraints
  • 12.3 Anesthesia Drugs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Anesthesia Drugs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Anesthesia Drugs
  • 13.3 Anesthesia Drugs Production Process
  • 13.4 Anesthesia Drugs Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Anesthesia Drugs Typical Distributors
  • 14.3 Anesthesia Drugs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Anesthesia Drugs market size was valued at USD 4069.1 million in 2023 and is forecast to a readjusted size of USD 5091.4 million by 2030 with a CAGR of 3.3% during review period.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    The Global Info Research report includes an overview of the development of the Anesthesia Drugs industry chain, the market status of Intravenous Anesthetics (Propofol, Etomidate), Inhalational Anesthetics (Propofol, Etomidate), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Anesthesia Drugs.
    Regionally, the report analyzes the Anesthesia Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Anesthesia Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Anesthesia Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Anesthesia Drugs industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Propofol, Etomidate).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Anesthesia Drugs market.
    Regional Analysis: The report involves examining the Anesthesia Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Anesthesia Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Anesthesia Drugs:
    Company Analysis: Report covers individual Anesthesia Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Anesthesia Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Intravenous Anesthetics, Inhalational Anesthetics).
    Technology Analysis: Report covers specific technologies relevant to Anesthesia Drugs. It assesses the current state, advancements, and potential future developments in Anesthesia Drugs areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Anesthesia Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Anesthesia Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
    Market segment by Type
    Propofol
    Etomidate
    Midazolam
    Sevoflurane
    Isoflurane
    Market segment by Application
    Intravenous Anesthetics
    Inhalational Anesthetics
    Major players covered
    Astrazeneca
    Fresenius-Kabi
    AbbVie
    Baxter Healthcare
    B.Braun
    Maruishi
    Piramal
    Hikma Pharmaceuticals
    Mylan
    Nhwa
    Hengrui
    Lunan
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Anesthesia Drugs product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Anesthesia Drugs, with price, sales, revenue and global market share of Anesthesia Drugs from 2019 to 2024.
    Chapter 3, the Anesthesia Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Anesthesia Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Anesthesia Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Anesthesia Drugs.
    Chapter 14 and 15, to describe Anesthesia Drugs sales channel, distributors, customers, research findings and conclusion.

    Buy now